Who owns ROCKET PHARMACEUTICALS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of RCKT from SEC Form 13F filings across 180 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 180 institutions disclosed 99.7M shares of ROCKET PHARMACEUTICALS, INC. worth $340.9M — about 88.3% of shares outstanding; the largest disclosed holder is RTW INVESTMENTS, LP. Source: SEC Form 13F filings, parsed by EvidInvest.
180
13F holders
$340.9M
value, 2026 filers
88.3%
of shares outstanding (99.7M sh)
21
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of RCKT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | RTW INVESTMENTS, LP | 17.7M | $60.5M | 0.5% | 15.7% | 0.0% |
| 2 | BlackRock, Inc. | 9.9M | $33.9M | 0.0% | 8.8% | +26.7% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.8M | $19.9M | 0.0% | 5.1% | +23.9% |
| 4 | CITIGROUP INC | 4.9M | $16.6M | 0.0% | 4.3% | -4.7% |
| 5 | MARSHALL WACE, LLP | 4.0M | $13.8M | 0.0% | 3.6% | +32.6% |
| 6 | MILLENNIUM MANAGEMENT LLC | 4.0M | $13.7M | 0.0% | 3.5% | +28.3% |
| 7 | Newtyn Management, LLC | 4.0M | $13.7M | 1.7% | 3.5% | +26.3% |
| 8 | MAVERICK CAPITAL LTD | 3.9M | $13.4M | 0.1% | 3.5% | +10.0% |
| 9 | VANGUARD CAPITAL MANAGEMENT LLC | 3.8M | $12.9M | 0.0% | 3.4% | +0.2% |
| 10 | AQR CAPITAL MANAGEMENT LLC | 3.4M | $11.6M | 0.0% | 3% | +10.3% |
| 11 | GOLDMAN SACHS GROUP INC | 2.8M | $9.7M | 0.0% | 2.5% | +64.6% |
| 12 | Monaco Asset Management SAM | 2.5M | $8.5M | 0.7% | 2.2% | +20.5% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 2.4M | $8.1M | 0.0% | 2.1% | +8.3% |
| 14 | FEDERATED HERMES, INC. | 2.3M | $7.9M | 0.0% | 2% | +125.1% |
| 15 | JPMORGAN CHASE & CO | 2.0M | $6.7M | 0.0% | 1.8% | +149.7% |
| 16 | JACOBS LEVY EQUITY MANAGEMENT, INC | 2.0M | $6.8M | 0.0% | 1.8% | +374.1% |
| 17 | STATE STREET CORP | 1.8M | $6.2M | 0.0% | 1.6% | -59.4% |
| 18 | DIMENSIONAL FUND ADVISORS LP | 1.1M | $3.8M | 0.0% | 1% | +290.4% |
| 19 | MORGAN STANLEY | 1.1M | $3.6M | 0.0% | 0.9% | -47.4% |
| 20 | Opaleye Management Inc. | 1.0M | $3.4M | 0.3% | 0.9% | +4.7% |
| 21 | D. E. Shaw & Co., Inc. | 950,552 | $3.3M | 0.0% | 0.8% | -56.2% |
| 22 | Jump Financial, LLC | 867,900 | $3.0M | 0.0% | 0.8% | +82.1% |
| 23 | RENAISSANCE TECHNOLOGIES LLC | 792,974 | $2.7M | 0.0% | 0.7% | +24.5% |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 749,073 | $2.6M | 0.0% | 0.7% | +3.4% |
| 25 | NORTHERN TRUST CORP | 735,090 | $2.5M | 0.0% | 0.7% | +14.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.